CALL FOR ABSTRACTS: #DIA2013 49th Annual Meeting: Advancing Therapeutic Innovation and Regulatory Science - deadline 9/12

http://www.diahome.org/en/Get-Involved/Submit-Abstracts/Submit-a-New-Abstract/Select-Meeting/Meeting-Details.aspx?productID=30075&productcode=13001

Meeting Date:
6/23/2013 8:30:00 AM - 6/27/2013 12:45:00 PM

Location:
Boston Convention and Exhibition Center 415 Summer Street, Boston, MA 02210 USA

Overview:

Call for Abstracts for DIA 2013 49th Annual Meeting opens as of August 6, 2012 with a deadline of September 12, 2012

· Read the Call for Abstracts to review specific guidelines for submitting an abstract for consideration

· Read Best Practices for submitting abstracts

DIA 2013 49th Annual Meeting: Advancing Therapeutic Innovation and Regulatory Science is the largest multidisciplinary event that brings together a global network of professionals to foster innovation that will lead to the development of safe and effective health care products.

Through increased access to training and expanded professional networking opportunities, DIA 2013 will:

· Provide a global unbiased platform to raise the level of discussion to facilitate innovation that will change the future of health care

· Provide comprehensive coverage of the full development and life cycle management process for all health care products Enhance your working relationship with colleagues, both locally and internationally

· Offer a holistic and integrated approach to the development and life cycle management of regulated health care products

Ultimately, collaboration is about mutual respect, working together, and being open to new ideas and learning from each other. To that end, DIA 2013 provides the best opportunity to meet with people from around the world, share your views and knowledge, network, and build new relationships.

Learning Objective:
At the conclusion of this meeting, participants should be able to:

• Describe the current regulatory and public policy environment pertaining to pharmaceuticals with an emphasis on the Food and Drug Administration;
• Discuss the international regulations and economic factors that impact the global biopharmaceutical industry;
• Recognize the challenges facing the FDA and the pharmaceutical industry in areas such as research study design and statistical methodology;
• Recognize state-of-the-art clinical and statistical systems and implementations;
• Recognize the written and communication skills needed to promote your career and your companys objectives;
• Enhance your working relationship with colleagues, both locally and internationally;
• Describe legal, advertising, and marketing issues related to providing product information;
• Discuss statistics, economics, and quality of life science;
• Enhance your knowledge of risk assessment and management in the areas such as computer systems validation and drug safety and pharmacovigilance;
• Discuss issues in safety reporting, data analysis, epidemiology, and regulations regarding adverse events.

Target Audience:
This program is designed for the full continuum of disciplines in the pharmaceutical and related industries to improve your understanding and skills as related to issues and solutions for a variety of pharmaceutical development interest areas.